This section should offer the reviewer a comprehensive overview of the clinical pharmacology studies, including those conducted to assess human pharmacokinetics (PK) and pharmacodynamics (PD), as well as relevant in vitro studies using human cells, tissues, or biomaterials related to PK processes.

Read the full ICH guidance.